OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non–Small Cell Lung Cancer
Ping Lü, Yifei Ma, Jindan Kai, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 11

Showing 11 citing articles:

Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence
Chuanlong Zhang, Mengqi Gao, Xiaochen Jiang, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 1294-1307
Open Access | Times Cited: 36

Advanced lung cancer inflammation index (ALI) predicts prognosis of patients with gastric cancer after surgical resection
Xin Zhang, Danfang Wang, Tuanhe Sun, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 26

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
Kah Yee Goh, Terence You De Cheng, Su Chin Tham, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 508-508
Open Access | Times Cited: 14

Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review
Kim Oren Gradel
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6132-6132
Open Access | Times Cited: 12

Novel Diagnostic and Prognostic Tools for Lung Cancer Cachexia: Based on Nutritional and Inflammatory Status
Chenan Liu, Qi Zhang, Guo‐Tian Ruan, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12

Exploring the impact of patient‐specific clinical features on osimertinib effectiveness in a real‐world cohort of patients with EGFR mutated non‐small cell lung cancer
Ard van Veelen, G. Veerman, Marjon V. Verschueren, et al.
International Journal of Cancer (2023) Vol. 154, Iss. 2, pp. 332-342
Open Access | Times Cited: 6

Advanced Lung Cancer Inflammation Index: A Novel Comprehensive Biomarker of Host Status for Patients with Metastatic Colorectal Cancer
Taichi Horino, Ryuma Tokunaga, Yuji Miyamoto, et al.
Journal of the Anus Rectum and Colon (2024) Vol. 8, Iss. 3, pp. 137-149
Open Access | Times Cited: 1

The role of immunotherapy in lung cancer: Actual scenery
İpek Ertorun, Aydan Hüseynli, Sevinc Nursena Ertekın, et al.
European Journal of Life Sciences (2023) Vol. 2, Iss. 1, pp. 45-51
Open Access | Times Cited: 1

Page 1

Scroll to top